Posterior to the ridge laser treatment for severe stage 3 retinopathy of prematurity

Eye (Basingstoke)

Volumn 27, Issue 4, 2013, Pages 525-530

  Ells, A L ^a,b   Gole, G A ^c   Lloyd Hildebrand, P ^d   Ingram, A ^a   Wilson, C M ^e,f   Geoff Williams, R ^b,g  

^a Ells Retina Centre   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e CITY UNIVERSITY   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g Calgary Retina Consultants   (Canada)

Author keywords

laser photocoagulation; neovascular ridge; posterior laser treatment; retinopathy of prematurity

Indexed keywords

BIRTH WEIGHT; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LASER COAGULATION; MALE; MEDICAL RECORD REVIEW; POSTERIOR LASER PHOTOCOAGULATION; RETINA; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; VASODILATATION; VITRECTOMY;

EID: 84876126966     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.302     Document Type: Review

References (27)

1. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005; 115(5): e518-e525.
2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 2001; 119(8): 1110-1118.
3. Repka MX, Tung B, Good WV, Shapiro M, Capone Jr, A, Baker JD et al. Outcome of eyes developing retinal detachment during the early treatment for retinopathy of prematurity study (ETROP). Arch Ophthalmol 2006; 124(1): 24-30.
4. Good WV. Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; 102: 233-48; discussion 248-50.
5. Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate 2005; 88(3): 237-244.
6. Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004; 14(Suppl A): S140-S144.
7. Kushner BJ, Essner D, Cohen IJ, Flynn JT. Retrolental fibroplasia. II. pathologic correlation. Arch Ophthalmol 1977; 95(1): 29-38.
8. Palmer EA, Hardy RJ, Dobson V, Phelps DL, Quinn GE, Summers CG et al. 15-Year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005; 123(3): 311-318.
9. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251g. Arch Ophthalmol 2002; 120(5): 595-599.
10. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123(7): 991-999.
11. Lanzetta P, Furlan F, Morgante L, Veritti D, Bandello F. Nonvisible subthreshold micropulse diode laser (810nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008; 18(6): 934-940.
12. Frambach DA, Marmor MF. The rate and route of fluid resorption from the subretinal space of the rabbit. Invest Ophthalmol Vis Sci 1982; 22(3): 292-302.
13. Schmidt D. Macular-threatening traction detachment of the retina in diabetic proliferative retinopathy, treated by laser. Int Ophthalmol 1997; 21(2): 99-106.
14. Kain HL. Chorioretinal adhesion after argon laser photocoagulation. Arch Ophthalmol 1984; 102(4): 612-615.
15. Menchini U, Trabucchi G, Brancato R, Cappellini A. Can the diode laser (810nm) effectively produce chorioretinal adhesion? Retina 1992; 12(3 Suppl): S80-S86
16. Chan-Ling T, Chu Y, Baxter L, Weible Ii M, Hughes S. In vivo characterization of astrocyte precursor cells (APCs) and astrocytes in developing rat retinae: differentiation, proliferation, and apoptosis. Glia 2009; 57(1): 39-53.
17. Chan-Ling T, Page MP, Gardiner T, Rosinova E, Hughes S. Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 2004; 165(4): 1301-1313.
18. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996; 114(10): 1219-1228.
19. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92(3): 905-909.
20. Hindle NW, Leyton J. Prevention of cicatricial retrolental fibroplasia by cryotherapy. Can J Ophthalmol 1978; 13(4): 277-282.
21. Axer-Siegel R, Maharshak I, Snir M, Friling R, Ehrlich R, Sherf I et al. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina 2008; 28(6): 839-846.
22. Axer-Siegel R, Snir M, Cotlear D, Maayan A, Frilling R, Rosenbaltt I et al. Diode laser treatment of posterior retinopathy of prematurity. Br J Ophthalmol 2000; 84(12): 1383-1386.
23. O'Keefe M, Burke J, Algawi K, Goggin M. Diode laser photocoagulation to the vascular retina for progressively advancing retinopathy of prematurity. Br J Ophthalmol 1995; 79(11): 1012-1014.
24. Steinmetz RL, Brooks Jr., HL. Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity. Retina 2002; 22(1): 48-52.
25. Axer-Siegel R, Snir M. Diode laser photocoagulation to the ridge and avascular retina in threshold retinopathy of prematurity. Retina 2003; 23(1): 126-127; author reply 127.
26. Darlow BA, Ells AL, Gilbert CE, Gole GA, Quinn GE. Are we there yet? Bevacizumab therapy for retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2011; e-pub ahead of print 30 December 2011; doi:10.1136/ archdischild-2011-301148.
27. Gole GA, Camuglia JE, Ells AL. Bevacizumab for retinopathy of prematurity. N Engl J Med 2011; 364(24): 2360-2361.